Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 3—March 2016
Research

Whole-Genome Sequencing to Determine Origin of Multinational Outbreak of Sarocladium kiliense Bloodstream Infections

Kizee A. EtienneComments to Author , Chandler C. Roe, Rachel Smith, Snigdha Vallabhaneni, Carolina Duarte, Patricia Escandón, Elizabeth Castañeda, Beatriz L. Gómez, Catalina de Bedout, Luisa F. López, Valentina Salas, Luz Maria Hederra, Jorge Fernández, Paola Pidal, Juan Carlos Hormazabel, Fernando Otaíza-O’Ryan, Fredrik O. Vannberg, John Gillece, Darrin Lemmer, Elizabeth M. Driebe, David M. Engelthaler, and Anastasia P. Litvintseva
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (K.A. Etienne, R.M. Smith, S. Vallabhaneni, A.P. Litvintseva); Georgia Institute of Technology, Atlanta (K.A. Etienne, F.O. Vannberg); Translational Genomics Research Institute, Flagstaff, Arizona, USA (C.C. Roe, J. Gillece, D. Lemmer, E.M. Driebe, D.M. Engelthaler); Instituto Nacional de Salud, Bogota, Colombia (C. Duarte, P. Escandón, E. Castañeda); Universidad del Rosario, Bogota (B.L. Gómez); Corporación para Investigaciones Biológicas, Medellín, Colombia (B.L. Gómez, C. de Bedout, L.F. López); Instituto de Salud Publica de Chile, Santiago, Chile (V. Salas, L.M. Hederra, J. Fernández, P. Pidal, J.C. Hormazabel); Ministry of Health, Santiago (F. Otaíza-O’Ryan)

Main Article

Figure

Whole-genome single-nucleotide polymorphism (SNP) typing of Sarocladium kiliense strains, Chile and Colombia, 2013–2014. All patient (clinical) and drug (vial) isolates from these 2 countries differed by <5 SNPs, and >21,000 SNPs were identified for the control isolates (≈117,000 total SNPs, ≈73,000 parsimoniously informative SNPs). Scale bar indicates nucleotide substitutions per site.

Figure. Whole-genome single-nucleotide polymorphism (SNP) typing of Sarocladium kiliense strains, Chile and Colombia, 2013–2014. All patient (clinical) and drug (vial) isolates from these 2 countries differed by <5 SNPs, and >21,000 SNPs were identified for the control isolates (≈117,000 total SNPs, ≈73,000 parsimoniously informative SNPs). Scale bar indicates nucleotide substitutions per site.

Main Article

Page created: February 17, 2016
Page updated: February 17, 2016
Page reviewed: February 17, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external